Organization | Melaka Manipal Medical College

Melaka Manipal Medical College Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Manipal India (1953)

Organization Overview

First Clinical Trial

2008

NCT00864383

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Dr.Nirmal Kumar Jain, Jaipur, India | Jenny Bajracharya | KMC, Mangalore | Manipal Hospital, India | Manipal University | Melaka Manipal Medical College | Melaka Manipal Medical College,Faculty of Dentistry, Manipal Academy of Higher Education

Active Ingredients

Drugs in Phase 4 Trials (4)

acetaminophen (tylenol) (1 trial)

articaine (Septocaine) (1 trial)

epinephrine (levophed) (1 trial)

mepivacaine (carbocaine) (1 trial)

Drugs in Phase 3 Trials (5)

ethambutol (myambutol) (1 trial)

isoniazid (nydrazid) (1 trial)

moxifloxacin (avelox) (1 trial)

pyrazinamide (Aldinamide) (1 trial)

rifampin (1 trial)

Drugs in Phase 2 Trials (1)

allogeneic adipose derived mesenchymal stem cell (2 trials)

Drugs in Other Trials (2)

fentanyl (Innovar) (1 trial)

ketamine (ketalar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Fibrosis (Phase 2)

Ischemia (Phase 2)

Liver Cirrhosis (Phase 2)

Liver Cirrhosis, Alcoholic (Phase 2)

Thromboangiitis Obliterans (Phase 2)

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 12